Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Trendlines Group ( (SG:42T) ).
Trendlines Group has approved co-investments with entities related to its controlling shareholder Librae Holdings in two portfolio companies, Ceretrieve and Vensica Medical, totaling US$1.4 million, split between LH-related parties and Trendlines. The capital will be deployed via a SAFE in Ceretrieve and a share purchase in Vensica, aiming to support ongoing operations, R&D, and clinical trials while positioning both companies for future exit opportunities.
The board emphasized that the transactions were conducted on normal commercial terms, with no special influence from LH-related entities and with all necessary approvals secured. Trendlines expects no material impact on its net tangible assets or earnings per share, but believes the participation of its controlling shareholder’s related companies enhances its ability to attract additional strategic investors and ultimately improve exit outcomes for shareholders.
More about Trendlines Group
Trendlines Group Ltd., incorporated in Israel and listed on Singapore’s Catalist board, operates as an investment and incubation group focused on developing portfolio companies, particularly in medical and healthcare technologies. The company partners with strategic investors and supportive shareholders to fund growth, accelerate research and development, and position its investees for successful exits in global markets.
Average Trading Volume: 3,223,822
Technical Sentiment Signal: Buy
Current Market Cap: S$90.24M
For an in-depth examination of 42T stock, go to TipRanks’ Overview page.